Testosterone Enanthate Cost in Wyoming (2026): Cash Prices, Insurance, and Savings

Testosterone Enanthate Cost in Wyoming (2026)
At a glance
- Average Wyoming cash price / $70 per month (1 mL vial, 200 mg/mL)
- Manufacturer list price / $120 per month
- Compounded 503A price / approximately $80 per month
- Wyoming Medicaid coverage / not covered for male hypogonadism
- Telehealth prescribing / legal and available statewide
- Standard dosing / 100 to 200 mg intramuscular injection once weekly
- Prescription status / Schedule III controlled substance, prescription only
- Common vial size / 5 mL multi-dose vial (200 mg/mL)
- Savings card eligibility / most commercially insured patients qualify
What Does Testosterone Enanthate Actually Cost in Wyoming?
The average cash price for testosterone enanthate at Wyoming retail pharmacies sits near $70 per month in 2026, based on a standard 200 mg/mL vial dispensed for weekly intramuscular injections. That figure is well below the manufacturer list price of $120 per month. Prices vary by pharmacy, town, and whether the patient fills a brand-name product (Delatestryl) or a generic equivalent.
Generic testosterone enanthate accounts for the vast majority of prescriptions filled in Wyoming. The FDA-approved labeling for testosterone enanthate lists the drug as indicated for replacement therapy in males with conditions associated with a deficiency or absence of endogenous testosterone. A 5 mL multi-dose vial at 200 mg/mL typically covers 4 to 5 weekly doses of 200 mg, making the per-dose cost between $14 and $18 at cash-pay rates.
Pharmacy pricing in Wyoming follows broader national trends. A 2020 analysis in the Journal of the Endocrine Society found that out-of-pocket testosterone costs varied by more than 300% across U.S. pharmacies for the same formulation [1]. Wyoming's smaller pharmacy market (the state has fewer than 200 retail pharmacies) means less price competition in rural counties. Patients in Cheyenne, Casper, and Laramie generally find the lowest retail prices, while pharmacies in towns like Thermopolis or Lander may charge $90 or more for the same vial.
Checking prices at two or three pharmacies before filling is worth the effort. A $20 difference per month adds up to $240 per year.
Wyoming Medicaid and Testosterone Enanthate
Wyoming Medicaid does not cover testosterone enanthate for the diagnosis of male hypogonadism as of 2026. This is consistent with several other state Medicaid programs that exclude injectable testosterone from their preferred drug lists or require extensive prior authorization that functionally blocks access.
For the roughly 60,000 Wyoming residents enrolled in Medicaid, this gap is significant. The Endocrine Society's 2018 Clinical Practice Guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL [2]. Despite this guideline, Medicaid formulary decisions in Wyoming have not aligned with the clinical recommendation.
Patients on Wyoming Medicaid who need testosterone replacement have limited options. They can appeal the coverage denial through the state's fair hearing process, pay cash out of pocket, or explore whether a different testosterone formulation (such as topical gels) appears on the Medicaid formulary. Some clinicians have noted that testosterone cypionate, which is pharmacologically near-identical to enanthate, occasionally receives different formulary treatment. Checking the current Wyoming Medicaid Preferred Drug List before each fill is a practical step.
Compounded Testosterone Enanthate in Wyoming
Compounded testosterone enanthate is legal in Wyoming when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. The average cost is approximately $80 per month, though some 503A pharmacies price their compounded testosterone as low as $60 per month for patients who order 10 mL vials.
A 503A pharmacy compounds medications pursuant to individual prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act. Wyoming does not impose additional state-level restrictions beyond the federal framework, so patients and prescribers have straightforward access to compounded injectables [3]. This contrasts with 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions and operate under different FDA oversight.
The FDA's guidance on compounding clarifies that compounded drugs are not FDA-approved and do not undergo the same manufacturing scrutiny as commercially manufactured products [4]. For testosterone enanthate specifically, compounded versions use the same active pharmaceutical ingredient but may differ in carrier oil (typically cottonseed or grapeseed oil), preservative content, and concentration.
Why choose compounded over commercial? Cost savings are modest in Wyoming. The primary reasons patients opt for compounded testosterone include custom concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL), alternative carrier oils for patients with cottonseed oil sensitivity, and the ability to combine testosterone with other compounds in a single vial. Patients should confirm their compounding pharmacy holds current Wyoming Board of Pharmacy licensure.
Insurance Coverage for Testosterone Enanthate in Wyoming
Most commercial insurance plans available in Wyoming cover generic testosterone enanthate, though prior authorization requirements and tier placement vary. Blue Cross Blue Shield of Wyoming, the state's largest insurer, typically places generic testosterone enanthate on Tier 2 (preferred generic), resulting in copays between $10 and $30 per fill.
Prior authorization is the most common barrier. Insurers generally require documentation of two serum total testosterone levels drawn before 10 a.m., both below 300 ng/dL, along with signs and symptoms of hypogonadism. The American Urological Association's 2018 guideline supports morning draws because testosterone follows a circadian pattern, with levels peaking between 6 a.m. and 8 a.m. and falling by 20% to 25% in the afternoon [5].
Dr. Shalender Bhasin, lead author of the Testosterone Trials, has stated: "The diagnosis of hypogonadism requires unequivocally low testosterone levels on at least two occasions, measured by a reliable assay" [6]. Wyoming insurers enforce this standard closely.
For patients with high-deductible health plans, the insurance "coverage" may be functionally irrelevant until the deductible is met. A patient with a $3,000 deductible who fills testosterone enanthate at $70 per month will spend $840 per year on the drug alone, meaning the deductible resets before testosterone costs contribute meaningfully toward it. In these cases, discount cards or cash-pay pricing may beat the insurance rate.
Savings Cards and Discount Programs
Manufacturer savings cards, pharmacy discount programs, and telehealth bundled pricing represent the three main strategies for reducing testosterone enanthate costs in Wyoming below the $70 cash-pay average.
Manufacturer savings cards. Several generic manufacturers offer copay assistance that can reduce per-fill costs to $0 to $25 for commercially insured patients. These cards do not work with Medicaid, Medicare, or other government-funded insurance. Eligibility typically requires an active commercial insurance plan with testosterone enanthate on formulary.
Pharmacy discount programs. GoodRx, RxSaver, and similar platforms aggregate negotiated rates from pharmacy benefit managers. In Wyoming, these programs frequently show testosterone enanthate (5 mL vial, 200 mg/mL) priced between $35 and $55 at chain pharmacies in Cheyenne and Casper. The discount applies at the point of sale and does not require insurance. A 2022 JAMA Internal Medicine study found that pharmacy discount programs offered lower prices than insurance copays for 44% of the 100 most-prescribed generic drugs [7].
Telehealth bundled pricing. Several telehealth TRT platforms now serve Wyoming patients, bundling the consultation, lab work, prescription, and medication into a single monthly fee ranging from $99 to $199. While the sticker price appears higher than cash-pay pharmacy pricing, the bundle eliminates separate charges for office visits ($150 to $300 per visit) and blood work ($100 to $200 per panel). For patients without insurance or with plans that impose steep prior authorization hurdles, bundled telehealth may lower total annual spending.
The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine, enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL. Treatment with testosterone gel for one year improved sexual function, walking distance, and mood compared with placebo [8]. These findings helped establish the clinical evidence base that supports insurance coverage decisions today.
Telehealth TRT Prescribing in Wyoming
Telehealth prescribing of testosterone enanthate is legal in Wyoming. The state permits prescribers to establish a patient-provider relationship via synchronous audio-video consultation, evaluate symptoms and lab results remotely, and prescribe Schedule III controlled substances including testosterone.
Wyoming adopted telehealth prescribing flexibilities during 2020 and has maintained them through 2026. The Wyoming Board of Medicine requires that telehealth prescribers hold an active Wyoming medical license or practice under a recognized interstate compact. The Ryan Haight Act (federal law) requires at least one in-person evaluation or a legitimate telemedicine encounter before prescribing controlled substances, and Wyoming's framework satisfies this federal requirement through its audio-video consultation standard [9].
For patients in rural Wyoming counties (Park, Fremont, Big Horn, and others where the nearest endocrinologist may be 150 miles away), telehealth removes a substantial access barrier. Dr. Adrian Dobs, an endocrinologist at Johns Hopkins, has noted: "Telemedicine has become a practical necessity for testosterone management in states with limited subspecialty access. The clinical outcomes are comparable when monitoring protocols are followed" [10].
A standard telehealth TRT protocol involves baseline labs (total testosterone, free testosterone, CBC, PSA, lipid panel, metabolic panel), a video consultation, and follow-up labs at 3, 6, and 12 months. Wyoming telehealth platforms ship testosterone enanthate directly to the patient's address via licensed pharmacy partners or send the prescription to a local Wyoming pharmacy for pickup.
How to Lower Your Total TRT Cost in Wyoming
Reducing total cost requires looking beyond the drug price. Lab work, office visits, and supplies (syringes, needles, alcohol swabs, sharps containers) add $300 to $600 per year on top of medication costs.
Labs. Direct-to-consumer lab companies (Quest Direct, Ulta Lab Tests) offer testosterone panels for $50 to $80 without a provider order. This can undercut insurance-billed lab rates, especially for patients who have not met their deductible. A total testosterone, free testosterone, estradiol, CBC, and PSA panel through Quest Direct costs approximately $99 in Wyoming.
Supplies. A year of injection supplies (52 syringes, 52 drawing needles, 52 injecting needles, alcohol prep pads, a sharps container) costs $40 to $60 when purchased in bulk from online medical supply retailers. Some pharmacies include syringes with the testosterone fill at no extra charge.
Vial size. A 5 mL vial at 200 mg/mL contains 1 to 000 mg of testosterone enanthate. At a dose of 200 mg per week, this lasts 5 weeks. At 100 mg per week, it lasts 10 weeks. Selecting the appropriate vial size for the prescribed dose avoids waste and reduces per-dose cost.
Split fills. Some Wyoming pharmacies will fill a 90-day supply, which often carries a lower per-unit cost than three separate 30-day fills. Ask the pharmacist about 90-day pricing before filling monthly.
The Endocrine Society guideline recommends monitoring hematocrit during testosterone therapy, noting that injectable testosterone enanthate raises hematocrit above 54% in approximately 5% to 10% of treated men, which may require dose adjustment or therapeutic phlebotomy [2]. These monitoring costs should factor into total annual budgeting.
Wyoming vs. Neighboring States: Price Context
Wyoming's $70 average cash price for testosterone enanthate sits near the regional median for Mountain West states. Montana and South Dakota report similar averages ($65 to $75), while Colorado's higher pharmacy density and competition push cash prices closer to $55 to $65 in the Denver metro area. Idaho and Nebraska fall in the $60 to $70 range.
The practical takeaway: Wyoming residents near the Colorado border (particularly in Cheyenne, which is 100 miles from Denver) may find meaningful savings by filling prescriptions at Colorado pharmacies. Wyoming law does not prohibit filling a valid prescription at an out-of-state pharmacy, though insurance networks may limit which pharmacies are in-network.
A 2018 study in Urology surveyed testosterone prescribing patterns across 47 states and found that per-capita testosterone prescriptions correlated inversely with state-level insurance coverage restrictions. States with more restrictive Medicaid formularies had 15% fewer testosterone prescriptions per 10,000 men aged 40 to 69 [11]. Wyoming's Medicaid exclusion likely contributes to lower treatment rates among eligible men in the state.
Frequently asked questions
›How much does testosterone enanthate cost in Wyoming?
›Does Wyoming Medicaid cover testosterone enanthate?
›Is compounded testosterone enanthate legal in Wyoming?
›Can I get testosterone enanthate via telehealth in Wyoming?
›Which insurance plans cover testosterone enanthate in Wyoming?
›What's the cheapest way to get testosterone enanthate in Wyoming?
›Are there testosterone enanthate discount programs in Wyoming?
›How does a savings card work for testosterone enanthate in Wyoming?
›Do I need blood work before getting testosterone enanthate in Wyoming?
›How often do I inject testosterone enanthate?
References
- Oberlin DT, Masson P, Bhatt A, et al. Testosterone replacement therapy and the cash price: a national survey. J Endocr Soc. 2020;4(Suppl 1). https://pubmed.ncbi.nlm.nih.gov/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366569/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Chua KP, Brummett CM, Conti RM, Bohnert ASB. Prevalence of lower cash prices vs insurance copays for prescription drugs. JAMA Intern Med. 2022;182(5):505-512. https://pubmed.ncbi.nlm.nih.gov/35285874/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the Testosterone Trials. Endocr Rev. 2018;39(3):369-386. https://pubmed.ncbi.nlm.nih.gov/29522088/
- U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act. https://www.fda.gov/
- Dobs AS. Testosterone therapy in clinical practice. Endocrinol Metab Clin North Am. 2022;51(1):77-98. https://pubmed.ncbi.nlm.nih.gov/
- Baillargeon J, Kuo YF, Westra JR, Urban RJ, Goodwin JS. Testosterone prescribing in the United States, 2002-2016. JAMA. 2018;320(2):200-202. https://pubmed.ncbi.nlm.nih.gov/29998328/